Lupus nephritis
Systemic lupus erythematosis (SLE) is an autoimmune disease of unknown etiology characterized by multi-system damage accompanied by the formation of multiple autoantibodies. The patient's body can produce antibodies against the antigens of the cell nucleus, cytoplasm and membrane. Clinical manifestations include fever, facial erythema, polymorphic rash, photosensitivity, multiple oral ulcers, arthritis, polyserositis, vasculitis, nephritis and central nervous system symptoms. The disease varies greatly and is often misdiagnosed or missed due to the prominent lesions of a certain system or organ. Those with kidney damage as the main manifestation are called systemic lupus erythematosus nephritis.
-
Site of disease:
kidney -
Infectious :
Not contagious -
Frequent population:
Women of childbearing age, 20-40 years old. -
Related symptoms:
Lymph node enlargement Tube-shaped urine Hepatosplenomegaly Ascites Facial butterfly erythema -
Concurrent disease:
Related Drugs
Leflunomide Tablets
Indication: 1. Suitable for adult rheumatoid arthritis, and has the effect of improving the condition. 2. Lupus nephritis.
Manufacturer:
Merro Pharmaceutical Co., Ltd.
Leflunomide Tablets
Indication: 1. Suitable for adult rheumatoid arthritis, and has the effect of improving the condition. 2. Lupus nephritis.
Leflunomide Capsules
Indication: 1. Suitable for adult rheumatoid arthritis, and has the effect of improving the condition. 2. Lupus nephritis.
Manufacturer:
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Kunming Mountain Begonia Slices
Manufacturer:
Yunnan Weihe Pharmaceuticals Co., Ltd.
Related Ingredients